Stephen Ferber, MD
- Call 216.444.5812
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Stephen Ferber, MD
Dr. Stephen Ferber currently serves as the Assistant Director of The Psychiatric Treatment-Resistance Program at Cleveland Clinic. He has extensive experience in the management of treatment-resistant mental health conditions, specializing in interventional psychiatry with a focus on Transcranial Magnetic Stimulation (TMS), Ketamine, and Electroconvulsive Therapy (ECT). Dr. Ferber’s research has focused on targeting strategies in TMS, and he maintains active membership in the International Society for ECT and Neurostimulation as well as the Clinical TMS Society. He has also devoted significant time to medical student and residency education, developing numerous didactics and electives focusing on circuit-based care and the utilization of the primary interventional modalities.
Education & Professional Highlights
Appointed
2023
Education & Fellowships
Fellowship - Massachusetts General Hospital
Interventional Neuropsychiatry and Neuromodulation
Boston,
MA
2021
Residency - Columbia University Medical Center-New York Presbyterian Hospital
Psychiatry
New York,
NY United States
2019
Medical Education - Herbert Wertheim College of Medicine
Miami,
FL
2015
Undergraduate - Carleton College
Psychology
Northfield,
MN United States
2011
Certifications
- Psychiatry and Neurology - Psychiatry
Specialty Interests
Interventional Psychiatry, Neuromodulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Ketamine, Treatment-Resistant Depression, Medical Education
Research & Publications
See publications for Stephen Ferber, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/1/2024, Dr. Ferber has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.